Samsara BioCapital
Biotech Investor · 7 portfolio companies
Portfolio
7
Combined Value
$470.0M
Focus Areas
13
Top Stage
Pre-clinical
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Neurogene | $470.0M |
| EyeBio | — |
| Alpheus Medical | — |
| OrsoBio | — |
| Medikine | — |
| Excellergy | — |
| Enara Bio | — |